Lin Tsung-Hsing, Yang Cheng-Chia, Lee Shih-Yu, Chang Ching-Mao, Tsai I-Ju, Wei Cheng-Yu, Yang Chun-Pai
Department of Emergency Medicine, Kuang Tien General Hospital, Taichung, Taiwan.
Department of Healthcare Administration, Asia University, Taichung, Taiwan.
Front Aging Neurosci. 2023 Jan 19;14:1041076. doi: 10.3389/fnagi.2022.1041076. eCollection 2022.
Migraine is a common disabling disorder, and its substantial burden is associated with a considerable negative impact on the patients' quality of life. Moreover, aging patients with migraine have more cognitive complaints. Additionally, the elderly are more likely to have sleep disturbances, which may also predict the risk of incident dementia. Migraines are reported to be closely associated with sleep and circadian rhythms. Sleep disturbance is a well-known trigger for migraine episodes; moreover, shift work or jet lag reportedly triggers some migraines. The hypothalamus is thought to be the migraine generator; sleep and circadian activity rhythm are also controlled by the hypothalamus. Evidence suggests an influence of both sleep and circadian system on migraine. Previously, light therapy has been show to stabilize sleep architecture and further improve insomnia related to circadian rhythm disorders. However, the beneficial effect of light therapy on migraine with sleep disturbance has not yet been determined. We aim to explore the effects of light therapy for migraine combined with sleep disturbance.
This project is a 2-year, randomized, double-blind, placebo-controlled clinical trial. The study design includes a 4-week monitoring period (baseline and pretest), a 4-week treatment period, and a posttest. The study participants will undergo assessments on headache frequency and severity and subjective and objective (wrist actigraphy and polysomnography) sleep disturbances, and quality of life and a series of blood tests for serum biomarkers.
This study will establish evidence-based alternative medicine for the preventive effect of bright light therapy in migraine patients with sleep disturbances. Moreover, our data will be useful to comprehend the biochemical mechanism of light therapy in migraine prevention.: ClinicalTrials.gov, identifier NCT04890691.
偏头痛是一种常见的致残性疾病,其沉重负担对患者的生活质量产生了相当大的负面影响。此外,老年偏头痛患者有更多认知方面的主诉。此外,老年人更易出现睡眠障碍,这也可能预示着发生痴呆症的风险。据报道,偏头痛与睡眠和昼夜节律密切相关。睡眠障碍是偏头痛发作的一个众所周知的触发因素;此外,据报道轮班工作或时差反应会引发一些偏头痛。下丘脑被认为是偏头痛的发病部位;睡眠和昼夜活动节律也受下丘脑控制。有证据表明睡眠和昼夜节律系统对偏头痛均有影响。此前,光照疗法已被证明可稳定睡眠结构并进一步改善与昼夜节律紊乱相关的失眠。然而,光照疗法对伴有睡眠障碍的偏头痛的有益效果尚未确定。我们旨在探讨光照疗法对合并睡眠障碍的偏头痛的影响。
本项目是一项为期2年的随机、双盲、安慰剂对照临床试验。研究设计包括一个为期4周的监测期(基线期和预测试期)、一个为期4周的治疗期和一次后测试。研究参与者将接受头痛频率和严重程度、主观和客观(手腕活动记录仪和多导睡眠图)睡眠障碍、生活质量评估以及一系列血清生物标志物血液检测。
本研究将为强光疗法对伴有睡眠障碍的偏头痛患者的预防作用建立循证替代医学依据。此外,我们的数据将有助于理解光照疗法预防偏头痛的生化机制。:ClinicalTrials.gov,标识符NCT04890691。